Skip to content
AusGrant
Federal Open GRANTS-GOV-362302

DoW Toxic Exposures Clinical Trial Award

Defense Health Agency Contracting Activity - DHACA (DOD) · Competitive grant · Science & Technology

At a glance

DoW Toxic Exposures Clinical Trial Award is a federal competitive grant from Defense Health Agency Contracting Activity - DHACA for the science & technology sector. Funding is up to $2K. Eligible applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility". The application deadline is November 19, 2026. Apply via the official listing at www.grants.gov.

Amount
Up to $2K
Deadline
Nov 19, 2026
Type
Competitive
Status
Open

About this program

Summary: The fiscal year 2026 (FY26) Toxic Exposures Research Program (TERP) Clinical Trial Award (CTA) mechanism supports the advancement, execution, and analysis of clinical trials with the potential to have a significant impact on the prevention, treatment, or management of symptoms, diseases or conditions associated with or resulting from military-related toxic exposures. Proposed projects may range from small proof-of-concept clinical trials (e.g., pilot, first-in-human, phase 0) designed to demonstrate the feasibility or inform the design of more advanced trials, through large-scale trials (including pragmatic clinical trials) to determine efficacy in relevant patient populations.  Distinctive Features: To encourage applications that include meaningful and productive collaborations, the FY26 TERP CTA includes a Partnering Principal Investigator Option (PPIO). One Principal Investigator (PI) is identified as the initiating PI, and an additional PI may be identified as a Partnering PI. If recommended for funding, each PI will be named on separate awards. The intent is to support interdisciplinary partnerships, such as those between clinicians and research scientists, that will accelerate the movement of promising interventions/​knowledge products into clinical applications. Partnering should significantly advance the research beyond what would be possible through independent efforts. https://cdmrp.health.mil/pubs/press/2026/terppreann

Who can apply

Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

How to apply

Apply through Grants.gov using funding opportunity number HT942526TERPCTA. Register your organization (SAM.gov + Grants.gov) before the deadline, then submit the application package listed in the official notice.

Apply at official source